Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells

Oncogene

Volumn 23, Issue 55, 2004, Pages 8979-8986

  Delmas, Dominique ^a   Rébé, Cédric ^b   Micheau, Olivier ^b   Athias, Anne ^c   Gambert, Philippe ^c   Grazide, Solène ^d   Laurent, Guy ^d   Latruffe, Norbert ^a   Solary, Eric ^b  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b INSERM   (France)

^c HÔPITAL DU BOCAGE   (France)

^d INSTITUT CLAUDIUS REGAUD   (France)

Author keywords

Apoptosis; Death receptors; Lipid rafts; Resveratrol

Indexed keywords

CASPASE; DEATH RECEPTOR; DEATH RECEPTOR 4; DEATH RECEPTOR 5; FAS ANTIGEN; LIGAND; NYSTATIN; PHYTOALEXIN; POLYPHENOL; PROTEIN; PROTEIN BCL 2; RESVERATROL; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL SURFACE; COLON CARCINOMA; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; DRUG SENSITIZATION; HUMAN; HUMAN CELL; LIPID RAFT; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

ANTIGENS, CD95; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; CARCINOMA; CASPASES; CELL LINE, TUMOR; COLONIC NEOPLASMS; FLOW CYTOMETRY; HUMANS; LIGANDS; LIPID METABOLISM; LIPIDS; MEMBRANE GLYCOPROTEINS; MEMBRANE MICRODOMAINS; MITOCHONDRIA; NYSTATIN; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; STILBENES; TIME FACTORS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 10644246821     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208086     Document Type: Article

References (41)

1. Algeciras-Schimnich A, Shen L, Barnhart BC, Murmann AE, Burkhardt JK and Peter ME. (2002). Mol. Cell. Biol., 22, 207-220.
2. Bernhard D, Tinhofer I, Tonko M, Hubl H, Ausserlechner MJ, Greil R, Kofler R and Csordas A. (2000). Cell Death Differ., 7, 834-842.
3. Boatright KM, Renatus M, Scott FL, Sperandio S, Shin H, Pedersen IM, Ricci JE, Edris WA, Sutherlin DP, Green DR and Salvesen GS. (2003). Mol. Cell, 11, 529-541.
4. Brakenhielm E, Cao R and Cao Y. (2001). FASEB J., 15, 1798-1800.
5. Chan SW, Hegyi L, Scott S, Cary NR, Weissberg PL and Bennett MR. (2000). Circ. Res., 86, 1038-1046.
6. Clement MV, Hirpara JL, Chawdhury SH and Pervaiz S. (1998). Blood, 92, 996-1002.
7. Delmas D, Rebe C, Lacour S, Filomenko R, Athias A, Gambert P, Cherkaoui-Malki M, Jannin B, Dubrez-Daloz L, Latruffe N and Solary E. (2003). J. Biol. Chem., 278, 41482-41490.
8. Donepudi M, Mac Sweeney A, Briand C and Grutter MG. (2003). Mol. Cell, 11, 543-549.
9. Dorrie J, Gerauer H, Wachter Y and Zunino SJ. (2001). Cancer Res., 61, 4731-4739.
10. Fulda S and Debatin KM. (2004). Cancer Res., 64, 337-346.
11. Garofalo T, Lenti L, Longo A, Misasi R, Mattei V, Pontieri GM, Pavan A and Sorice M. (2003). J. Biol. Chem., 277, 11233-11238.
12. Holler N, Tardivel A, Kovacsovics-Bankowski M, Hertig S, Gaide O, Martinon F, Tinel A, Deperthes D, Calderara S, Schulthess T, Engel J, Schneider P and Tschopp J. (2003). Mol. Cell. Biol., 23, 1428-1440.
13. Huang C, Ma WY, Goranson A and Dong Z. (1999). Carcinogenesis, 20, 237-242.
14. Hueber AO, Bernard AM, Herincs Z, Couzinet A and He HT. (2002). EMBO Rep., 3, 190-196.
15. Hueber AO. (2003). Cell Death Differ., 10, 7-9.
16. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC and Pezzuto JM. (1997). Science, 275, 218-220.
17. Joe AK, Liu H, Suzui M, Vural ME, Xiao D and Weinstein IB. (2002). Clin. Cancer Res., 8, 893-903.
18. Keane MM, Ettenberg SA, Nau MM, Russell EK and Lipkowitz S. (1999). Cancer Res., 59, 734-741.
19. Kubota T, Uemura Y, Kobayashi M and Taguchi H. (2003). Anticancer Res., 23, 4039-4046.
20. Lacour S, Hammann A, Grazide S, Lagadic-Gossmann D, Athias A, Sergent O, Laurent G, Gambert P, Solary E and Dimanche-Boitrel MT. (2004). Cancer Res., 64, 3593-3598.
21. Lacour S, Hammann A, Wotawa A, Corcos L, Solary E and Dimanche-Boitrel MT. (2001). Cancer Res., 61, 1645-1651.
22. Lacour S, Micheau O, Hammann A, Drouineaud V, Tschopp J, Solary E and Dimanche-Boitrel MT. (2003). Oncogene, 22, 1807-1816.
23. Lozupone F, Lugini L, Matarrese P, Luciani F, Federici C, Iessi E, Margutti P, Stassi G, Malorni W and Fais S. (2003). J. Biol. Chem., 279, 9199-9207.
24. Micheau O and Tschopp J. (2003). Cell, 114, 181-190.
25. Micheau O, Solary E, Hammann A and Dimanche-Boitrel MT. (1999). J. Biol. Chem., 274, 7987-7992.
26. Micheau O, Solary E, Hammann A, Martin F and Dimanche-Boitrel MT. (1997). J. Natl. Cancer Inst., 89, 783-789.
27. Micheau O, Thome M, Schneider P, Holler N, Tschopp J, Nicholson DW, Briand C and Grutter MG. (2002). J. Biol. Chem., 277, 45162-45171.
28. Muppidi JR and Siegel RM. (2004). Nat. Immunol., 5, 182-189.
29. Opipari Jr AW, Boitano AE, Sorenson DR, Aurora A and Liu JR. (2004). Cancer Res., 64, 696-703.
30. Pervaiz S. (2003). FASEB J., 17, 1975-1985.
31. Rohn TA, Wagenknecht B, Roth W, Naumann U, Gulbins E, Krammer PH, Walczak H and Weller M. (2001). Oncogene, 20, 4128-4137.
32. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH and Peter ME. (1998). EMBO J., 17, 1675-1687.
33. Scarlatti F, Sala G, Somenzi G, Signorelli P, Sacchi N and Ghidoni R. (2003). FASEB J., 17, 2339-2341.
34. Scheel-Toellner D, Wang K, Singh R, Majeed S, Raza K, Curnow SJ, Salmon M and Lord JM. (2002). Biochem. Biophys. Res. Commun., 97, 876-879.
35. Sheikh MS, Antinore MJ, Huang Y and Fornace Jr AJ. (1998). Oncogene, 17, 2555-2563.
36. Siegel RM, Frederiksen JK, Zacharias DA, Chan FK, Johnson M, Lynch D, Tsien RY and Lenardo MJ. (2000). Science, 288, 2354-2357.
37. Sun ZJ, Pan CE, Liu HS and Wang GJ. (2002). World J. Gastroenterol., 8, 79-81.
38. Thorburn A. (2004). Cell Signal., 16, 139-144.
39. Tinhofer I, Bernhard D, Senfter M, Anether G, Loeffler M, Kroemer G, Kofler R, Csordas A and Greil R. (2001). FASEB J., 15, 1613-1615.
40. Wieder T, Essmann F, Prokop A, Schmelz K, Schulze-Osthoff K, Beyaert R, Dorken B and Daniel PT. (2001). Blood, 97, 1378-1387.
41. Zoberi I, Bradbury CM, Curry HA, Bisht KS, Goswami PC, Roti JL and Gius D. (2002). Cancer Lett., 175, 165-173.